CD4 and cancer: It has been reported that miRNAs could have contradicting roles in different cell types, such as miR-21 example, which has been widely studied for its oncogenic role in various cancers and has been considered a potential therapeutic target in cancer therapy, but it also has pro-immune roles such as activating roles in CD4+ and CD8+ T cells (257, 258).